Nexus AG (0FGL.L)
EUR 71.3
(1.28%)
EUR 71.3
(1.28%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 2.81 Million EUR | 308.53% |
| 2022 | -1.34 Million EUR | 85.87% |
| 2021 | -9.54 Million EUR | 28.24% |
| 2020 | -13.29 Million EUR | 41.35% |
| 2019 | -22.66 Million EUR | -37.97% |
| 2018 | -16.43 Million EUR | 38.08% |
| 2017 | -26.53 Million EUR | -66.65% |
| 2016 | -15.92 Million EUR | 12.44% |
| 2015 | -18.18 Million EUR | -36.27% |
| 2014 | -13.34 Million EUR | 14.56% |
| 2013 | -15.61 Million EUR | -24.74% |
| 2012 | -12.52 Million EUR | -21.26% |
| 2011 | -10.32 Million EUR | 35.57% |
| 2010 | -16.02 Million EUR | -150.66% |
| 2009 | -6.39 Million EUR | -22.77% |
| 2008 | -5.2 Million EUR | -117.91% |
| 2007 | -2.39 Million EUR | 13.25% |
| 2006 | -2.75 Million EUR | 12.57% |
| 2005 | -3.15 Million EUR | -21.9% |
| 2004 | -2.58 Million EUR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -36 Thousand EUR | -101.28% |
| 2024 Q2 | 7.38 Million EUR | 20608.33% |
| 2024 Q3 | -12.51 Million EUR | -62.52% |
| 2023 Q4 | 2.81 Million EUR | -64.47% |
| 2023 Q2 | 13.2 Million EUR | 295.76% |
| 2023 FY | 2.81 Million EUR | 308.53% |
| 2023 Q3 | 7.91 Million EUR | -40.08% |
| 2023 Q1 | -6.74 Million EUR | -400.3% |
| 2022 Q1 | -31.38 Million EUR | -228.94% |
| 2022 Q2 | -20.52 Million EUR | 34.59% |
| 2022 Q3 | -1.39 Million EUR | 93.23% |
| 2022 Q4 | -1.34 Million EUR | 3.02% |
| 2022 FY | -1.34 Million EUR | 85.87% |
| 2021 Q3 | -7.14 Million EUR | 44.69% |
| 2021 FY | -9.54 Million EUR | 28.24% |
| 2021 Q4 | -9.54 Million EUR | -33.52% |
| 2021 Q1 | -28.92 Million EUR | -117.58% |
| 2021 Q2 | -12.92 Million EUR | 55.33% |
| 2020 Q1 | -40.95 Million EUR | -80.66% |
| 2020 Q2 | -40.7 Million EUR | 0.6% |
| 2020 Q3 | -18.02 Million EUR | 55.72% |
| 2020 FY | -13.29 Million EUR | 41.35% |
| 2020 Q4 | -13.29 Million EUR | 26.24% |
| 2019 Q2 | -26.23 Million EUR | 36.35% |
| 2019 Q1 | -41.22 Million EUR | -150.91% |
| 2019 FY | -22.66 Million EUR | -37.97% |
| 2019 Q4 | -22.66 Million EUR | -11.7% |
| 2019 Q3 | -20.29 Million EUR | 22.66% |
| 2018 FY | -16.43 Million EUR | 38.08% |
| 2018 Q1 | -32.63 Million EUR | -23.0% |
| 2018 Q2 | -19 Million EUR | 41.78% |
| 2018 Q3 | -19.14 Million EUR | -0.76% |
| 2018 Q4 | -16.43 Million EUR | 14.19% |
| 2017 Q1 | -26.45 Million EUR | -66.15% |
| 2017 Q2 | -23.65 Million EUR | 10.58% |
| 2017 Q3 | -22.21 Million EUR | 6.09% |
| 2017 Q4 | -26.53 Million EUR | -19.45% |
| 2017 FY | -26.53 Million EUR | -66.65% |
| 2016 Q4 | -15.92 Million EUR | 9.21% |
| 2016 Q2 | -24.64 Million EUR | 18.4% |
| 2016 Q1 | -30.2 Million EUR | -66.1% |
| 2016 FY | -15.92 Million EUR | 12.44% |
| 2016 Q3 | -17.53 Million EUR | 28.85% |
| 2015 FY | -18.18 Million EUR | -36.27% |
| 2015 Q3 | -14.92 Million EUR | 13.74% |
| 2015 Q1 | -19.38 Million EUR | -45.25% |
| 2015 Q2 | -17.29 Million EUR | 10.77% |
| 2015 Q4 | -18.18 Million EUR | -21.88% |
| 2014 Q3 | -16.89 Million EUR | -7.29% |
| 2014 Q4 | -13.34 Million EUR | 21.0% |
| 2014 Q2 | -15.74 Million EUR | 27.73% |
| 2014 Q1 | -21.78 Million EUR | -39.48% |
| 2014 FY | -13.34 Million EUR | 14.56% |
| 2013 Q3 | -15.81 Million EUR | -27.64% |
| 2013 Q4 | -15.61 Million EUR | 1.21% |
| 2013 FY | -15.61 Million EUR | -24.74% |
| 2013 Q2 | -12.38 Million EUR | 21.45% |
| 2013 Q1 | -15.76 Million EUR | -25.94% |
| 2012 Q2 | -13.51 Million EUR | 21.98% |
| 2012 Q3 | -11.55 Million EUR | 14.56% |
| 2012 Q1 | -17.32 Million EUR | -67.8% |
| 2012 Q4 | -12.52 Million EUR | -8.41% |
| 2012 FY | -12.52 Million EUR | -21.26% |
| 2011 FY | -10.32 Million EUR | 35.57% |
| 2011 Q2 | -17.38 Million EUR | 12.57% |
| 2011 Q1 | -19.87 Million EUR | -24.03% |
| 2011 Q4 | -10.32 Million EUR | 39.99% |
| 2011 Q3 | -17.2 Million EUR | 1.0% |
| 2010 Q2 | -8.59 Million EUR | 6.07% |
| 2010 FY | -16.02 Million EUR | -150.66% |
| 2010 Q4 | -16.02 Million EUR | -60.01% |
| 2010 Q3 | -10.01 Million EUR | -16.53% |
| 2010 Q1 | -9.15 Million EUR | -43.1% |
| 2009 Q4 | -6.39 Million EUR | 0.0% |
| 2009 FY | -6.39 Million EUR | -22.77% |
| 2008 FY | -5.2 Million EUR | -117.91% |
| 2007 FY | -2.39 Million EUR | 13.25% |
| 2006 FY | -2.75 Million EUR | 12.57% |
| 2005 FY | -3.15 Million EUR | -21.9% |
| 2004 FY | -2.58 Million EUR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Cegedim SA | 238.49 Million EUR | 98.821% |
| Guerbet SA | 313.3 Million EUR | 99.103% |
| Bastide Le Confort Médical SA | 333.35 Million EUR | 99.157% |
| Revenio Group Oyj | -2.8 Million EUR | 200.393% |
| Drägerwerk AG & Co. KGaA | 199.42 Million EUR | 98.59% |
| Sartorius Aktiengesellschaft | 4.89 Billion EUR | 99.943% |
| LNA Santé SA | 810.5 Million EUR | 99.653% |
| Siemens Healthineers AG | -1 Billion EUR | 100.279% |
| Medios AG | -53.89 Million EUR | 105.216% |
| Equasens Société anonyme | 50.84 Million EUR | 94.471% |
| Stratec SE | 107.83 Million EUR | 97.393% |